According to a prior study, patients with carcinoma had high levels of p-ERK1/2 and Ki-67 expression, and the ERK1/2 signaling pathway plays a role in both cancer growth and apoptosis (Chen et al., 2017). The gene discussed is MAPK3; the disease is carcinoma.